Most people have a relative, friend or neighbor who has had to deal with a cataract. Nearly 24.5 million Americans age 40 or older are affected by cataracts, and it’s the leading cause of blindness ...

Implanting intraocular lenses (IOLs) after cataract surgery in infants is neither beneficial nor detrimental to long-term visual outcomes, according to a study published in JAMA Ophthalmology. In this ...

An IOL-mounted sustained bimatoprost delivery system demonstrated a reduction in IOP in two clinical trials of patients with glaucoma or ocular hypertension, according to a press release from SpyGlass ...

A retrospective case-note review was undertaken of patients under 8 years old who underwent cataract surgery with primary lens implantation in a regional referral centre for paediatric ophthalmology, ...

Among children who underwent unilateral cataract removal in infancy, risk of glaucoma-related adverse events continues to increase with longer follow-up and is not associated with primary intraocular ...

Avoiding a Wrong Intraocular Lens Implant Despite implementation of the Safe Surgical Checklist, a review of current literature and statistics from ASCs and hospitals across the country demonstrate ...

New research uses an improved laboratory model to simulate cataract surgery on human donor eyes. Researchers at the University of East Anglia in collaboration with Hoya Surgical Optics have improved a ...

Launched in the month of World Sight Day, this next-generation monofocal intraocular lens is an advanced solution for post cataract surgery patients, that helps to meet the changing lifestyle needs of ...

Please provide your email address to receive an email when new articles are posted on . Multifocal intraocular lenses and accommodating intraocular lenses can be paired with a normal crystalline lens ...

Billing practices with respect to premium intraocular lenses (“IOLs”) implanted in surgery centers can create various risks for the surgery center. These risks arise when a physician supplies the ...

June 6, 2006 -- The European Commission has approved a medical device for the production of autologous serum injection containing high concentrations of interleukin-1 receptor antagonist for use in ...